Probiotix Health (FRA:X90) Total Receivables: €0.37 Mil (As of Dec. 2025)


What is Probiotix Health Total Receivables?

Probiotix Health FRA:X90 -6.71% Total Receivables is €0.37 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Probiotix Health's Total Receivables for the quarter that ended in Dec. 2025 was €0.37 Mil.

Probiotix Health Total Receivables Related Terms

Probiotix Health Total Receivables Historical Data

* Premium members only.

The historical data trend for Probiotix Health's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health Total Receivables Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial 0.00 0.50 0.29 0.29 0.37

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.75 0.29 1.00 0.37

Probiotix Health Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €0.37 Mil mean?
Probiotix Health (FRA:X90) has a Total Receivables of €0.37 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Probiotix Health and its competitors.
Is Probiotix Health's Total Receivables too high?
Probiotix Health's current Total Receivables is €0.37 Mil.
How does Probiotix Health's Total Receivables compare to VRTX and REGN?
Probiotix Health's Total Receivables of €0.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Probiotix Health and its competitors. Probiotix Health's current Total Receivables is €0.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current Total Receivables of €0.37 Mil. The stock's GF Value™ is €0.10, compared to a current price of €0.07 — trading 30.5% below its estimated fair value. The current Total Receivables is €0.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current Total Receivables is €0.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Probiotix Health Business Description

Other Exchanges PBX:UK
Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.